These results indicate that sPD-L1 may correlate with the in vivo deletion of activated T cells in the peripheral circulation, which may modulate the immune response in peripheral tissues, and participate in the negative correlation between circulating sPD-L1 levels and cancer prognosis. This evidence concerns the gene SPDL1 and cancer.